Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS at CLDX
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 3, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLDXCelldex Therapeutics, Inc.SVP OF REGULATORY AFFAIRS
Sales by reason
0
Routine
2
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jun 3, 2024Unusual
Sold 81.3% of their holdings
$2M58,369 shares at $33.65
- May 30, 2024Unusual
Sold 84.5% of their holdings
$1.3M38,719 shares at $34.07
- May 30, 2024Notice
Filed a notice to sell 97,088 shares
$3.5M97,088 shares
- Dec 8, 2021Plan not stated
Sold 5.1% of their holdings
$24k600 shares at $40.00
- Nov 1, 2021Plan not stated
Sold 5.1% of their holdings
$25k600 shares at $41.71
5 of 5
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Jun 29, 2026 | CLDX | SVP OF REGULATORY AFFAIRS | AwardedIncentive Stock Option (right to buy) | 95,000 | 95,000 | SEC | ||
| Jun 5, 2025 | Jun 9, 2025 | CLDX | SVP OF REGULATORY AFFAIRS | AwardedIncentive Stock Option (right to buy) | 82,000 | 82,000 | SEC | ||
| Jun 13, 2024 | Jun 17, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | AwardedIncentive Stock Option (right to buy) | 82,000 | 82,000 | SEC | ||
| Jun 3, 2024 | Jun 5, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Sold | 58,369 | $33.65 | $2M | 13,383 | SEC |
| Jun 3, 2024 | Jun 5, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Exercised or settledIncentive Stock Option (Right to Buy) | 64,658 | 23,023 | SEC | ||
| Jun 3, 2024 | Jun 5, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Exercised options | 64,658 | $10.25 | $663k | 71,752 | SEC |
| May 30, 2024 | Jun 3, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Sold | 38,719 | $34.07 | $1.3M | 7,094 | SEC |
| May 30, 2024 | Jun 3, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Exercised or settledIncentive Stock Option (Right to Buy) | 33,719 | 81,392 | SEC | ||
| May 30, 2024 | Jun 3, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Exercised options | 33,719 | $3.75 | $126k | 45,813 | SEC |
| Jun 15, 2023 | Jun 20, 2023 | CLDX | SVP OF REGULATORY AFFAIRS | AwardedIncentive Stock Option (right to buy) | 80,000 | 80,000 | SEC | ||
| Jun 16, 2022 | Jun 17, 2022 | CLDX | SVP OF REGULATORY AFFAIRS | AwardedIncentive Stock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Dec 8, 2021 | Dec 10, 2021 | CLDX | SVP of Regulatory Affairs | Sold | 600 | $40.00 | $24k | 11,247 | SEC |
| Dec 8, 2021 | Dec 10, 2021 | CLDX | SVP of Regulatory Affairs | Exercised or settledIncentive Stock Option (Right to Buy) | 600 | 41,800 | SEC | ||
| Dec 8, 2021 | Dec 10, 2021 | CLDX | SVP of Regulatory Affairs | Exercised options | 600 | $2.78 | $2k | 11,847 | SEC |
| Nov 1, 2021 | Nov 3, 2021 | CLDX | SVP of Regulatory Affairs | Sold | 600 | $41.71 | $25k | 11,247 | SEC |
| Nov 1, 2021 | Nov 3, 2021 | CLDX | SVP of Regulatory Affairs | Exercised or settledIncentive Stock Option (Right to Buy) | 600 | 42,400 | SEC | ||
| Nov 1, 2021 | Nov 3, 2021 | CLDX | SVP of Regulatory Affairs | Exercised options | 600 | $2.78 | $2k | 11,847 | SEC |
| Aug 11, 2021 | Aug 13, 2021 | CLDX | SVP of Regulatory Affairs | Exercised or settledIncentive Stock Option | 10,000 | 8,332 | SEC | ||
| Aug 11, 2021 | Aug 13, 2021 | CLDX | SVP of Regulatory Affairs | Exercised options | 10,000 | $9.02 | $90k | 11,247 | SEC |
| Jun 17, 2021 | Jun 21, 2021 | CLDX | SVP of Regulatory Affairs | AwardedIncentive Stock Option (right to buy) | 62,500 | 62,500 | SEC | ||
| Jun 18, 2020 | Jun 19, 2020 | CLDX | SVP of Regulatory Affairs | AwardedIncentive Stock Option (right to buy) | 84,000 | 84,000 | SEC | ||
| Jun 9, 2020 | Jun 10, 2020 | CLDX | SVP of Regulatory Affairs | Bought | 1,000 | $3.01 | $3k | 1,000 | SEC |
| Jun 19, 2019 | Jun 20, 2019 | CLDX | SVP of Regulatory Affairs | AwardedIncentive Stock Option (right to buy) | 43,000 | 43,000 | SEC | ||
| Jun 13, 2018 | Jun 15, 2018 | CLDX | SVP of Regulatory Affairs | AwardedIncentive Stock Option (right to buy) | 275,000 | 275,000 | SEC | ||
| Oct 3, 2017 | Oct 3, 2017 | CLDX | SVP of Regulatory Affairs | AwardedIncentive Stock Option (right to buy) | 75,000 | 75,000 | SEC |
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Jun 5, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Form 4 sale | 58,369 | $2M | 81.3% | Unusual | SEC |
| May 30, 2024 | Jun 3, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Form 4 sale | 38,719 | $1.3M | 84.5% | Unusual | SEC |
| May 30, 2024 | May 30, 2024 | CLDX | SVP OF REGULATORY AFFAIRS | Form 144 notice | 97,088 | $3.5M | Notice | SEC | |
| Dec 8, 2021 | Dec 10, 2021 | CLDX | SVP of Regulatory Affairs | Form 4 sale | 600 | $24k | 5.1% | Plan not stated | SEC |
| Nov 1, 2021 | Nov 3, 2021 | CLDX | SVP of Regulatory Affairs | Form 4 sale | 600 | $25k | 5.1% | Plan not stated | SEC |